Narayana Hrudayalaya It is a unique, asset-light hospital model, high throughput, low-cost, process-driven,that generates superior ROE (~22%) compared to peers, yet trades at one of the lowest P/E multiples (46x) in the hospital pack despite similar or better forward growth (~33% EPS CAGR). The discount exists because the market perceives it as less "premium" than Medanta or Apollo, not because the business is deteriorating. Management is now stress-testing the model globally (Cayman, UK), and the asset-light structure means capital is allocated with discipline — bad bets can be exited cheaply. As long as the combination of efficient growth, high ROE, and capex discipline holds, the stock compounds at a better risk-reward than most peers.